Cargando…

Biosimilars in paediatric inflammatory bowel disease

The introduction of biological treatments has changed disease outcomes for patients with inflammatory bowel disease. Biologicals have high efficacy, and can induce and maintain remission after failed responses to conventional immunosuppressive and/or steroid therapy. The increasing occurrence of sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sieczkowska-Golub, Joanna, Jarzebicka, Dorota, Oracz, Grzegorz, Kierkus, Jaroslaw
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148430/ https://www.ncbi.nlm.nih.gov/pubmed/30254406 http://dx.doi.org/10.3748/wjg.v24.i35.4021

Ejemplares similares

Usefulness of Colon Assessment by Magnetic Resonance Enterography in Pediatric Patients with Inflammatory Bowel Disease—Retrospective Case Series
por: Sieczkowska-Golub, Joanna, et al.
Publicado: (2021)

Achalasia in Children—Clinical Presentation, Diagnosis, Long-Term Treatment Outcomes, and Quality of Life
por: Jarzębicka, Dorota, et al.
Publicado: (2021)

Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study
por: Szymanska, Edyta, et al.
Publicado: (2021)

Biosimilars in inflammatory bowel disease: A review of post-marketing experience
por: Deiana, Simona, et al.
Publicado: (2017)

Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease
por: Szymanska, Edyta, et al.
Publicado: (2015)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Inflammatory bowel disease and airway diseases
por: Vutcovici, Maria, et al.
Publicado: (2016)

Combination therapy for inflammatory bowel disease
por: Sultan, Keith S, et al.
Publicado: (2017)

Food as Treatment of Inflammatory Bowel Diseases
por: Maldonado-Contreras, Ana
Publicado: (2022)

Necroptosis in inflammatory bowel disease and other intestinal diseases
por: Li, Sha, et al.
Publicado: (2018)

Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018)

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Enteroscopy in children and adults with inflammatory bowel disease
por: Di Nardo, Giovanni, et al.
Publicado: (2020)

Proteomic insights on the metabolism in inflammatory bowel disease
por: Pisani, Laura Francesca, et al.
Publicado: (2020)

Role of diet and nutrition in inflammatory bowel disease
por: de Castro, Marina Moreira, et al.
Publicado: (2021)

Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
por: Akiyama, Shintaro, et al.
Publicado: (2022)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
por: Tighe, Donal, et al.
Publicado: (2017)

Potential role of nutraceutical compounds in inflammatory bowel disease
por: Larussa, Tiziana, et al.
Publicado: (2017)

Sexual health and fertility for individuals with inflammatory bowel disease
por: Leenhardt, Romain, et al.
Publicado: (2019)

Emerging use of artificial intelligence in inflammatory bowel disease
por: Kohli, Arushi, et al.
Publicado: (2020)

Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases
por: Aggarwal, Surbhi, et al.
Publicado: (2021)

Novel drug delivery systems for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Updates in therapeutic drug monitoring in inflammatory bowel disease
por: Lodhia, Nilesh, et al.
Publicado: (2022)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Application of single-cell omics in inflammatory bowel disease
por: Zheng, Hengqi Betty
Publicado: (2023)

Autoimmune markers in children with chronic pancreatitis
por: Oracz, Grzegorz, et al.
Publicado: (2014)

Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease
por: Matuszczyk, Małgorzata, et al.
Publicado: (2022)

Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider?
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Insolation and Disease Severity in Paediatric Inflammatory Bowel Disease—A Multi-Centre Cross-Sectional Study
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2020)

Biological markers of disease activity in inflammatory bowel diseases
por: Szymanska, Edyta, et al.
Publicado: (2023)

The risk of cardiovascular complications in inflammatory bowel disease
por: Czubkowski, Piotr, et al.
Publicado: (2020)

Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment
por: Spiceland, Clayton M, et al.
Publicado: (2018)

Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
por: Wang, Alice Yuxin, et al.
Publicado: (2016)

Use and barriers to chromoendoscopy for dysplasia surveillance in inflammatory bowel disease
por: Shukla, Richa, et al.
Publicado: (2017)

Treating children with inflammatory bowel disease: Current and new perspectives
por: Guariso, Graziella, et al.
Publicado: (2017)

Effect of inflammatory bowel disease treatments on patients with diabetes mellitus
por: Bower, Joshua Ashley Jack, et al.
Publicado: (2021)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

Liver manifestations and complications in inflammatory bowel disease: A review
por: Gaspar, Rui, et al.
Publicado: (2021)

Shared decision-making in the management of patients with inflammatory bowel disease
por: Song, Kai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_905f134mq5aduen4ru211pqa3m